Psychosomatic Medicine Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brown, F. W.
Right arrow Articles by Smith, G. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brown, F. W.
Right arrow Articles by Smith, G. R., Jr

Psychosomatic Medicine, Vol 52, Issue 4 445-451, Copyright © 1990 by American Psychosomatic Society

ORIGINAL ARTICLES

Psychiatric comorbidity in primary care somatization disorder

FW Brown, JM Golding and GR Smith Jr
Department of Psychiatry, University of Arkansas for Medical Sciences, Little Rock 72205.

Lifetime prevalence rates were calculated for comorbid psychiatric disorders in 119 patients who were referred from primary care physicians for unexplained somatic complaints and who met DSM III-R criteria for somatization disorder. Comparisons were made with general population norms from the ECA study. Prevalence of nine comorbid conditions was significantly higher than in the general populations. The most prevalent comorbid diagnoses were major depression (54.6%), generalized anxiety disorder (33.6%), and phobic disorders (31.1%). The least common comorbid disorders were mania (4.2%) and drug abuse (4.9%); drug abuse prevalence rates did not significantly exceed general population estimates. Risk ratios were highest for panic disorder (16.25), major depression (9.41), schizophrenia (7.77), and obsessive-compulsive disorder (7.04).


This article has been cited by other articles:


Home page
 Psychosom. Med.Home page
R. Lieb, G. Meinlschmidt, and R. Araya
Epidemiology of the Association Between Somatoform Disorders and Anxiety and Depressive Disorders: An Update
Psychosom Med, November 1, 2007; 69(9): 860 - 863.
[Abstract] [Full Text] [PDF]

Home page
 Psychosom. Med.Home page
D. Hasin and H. Katz
Somatoform and Substance Use Disorders
Psychosom Med, November 1, 2007; 69(9): 870 - 875.
[Abstract] [Full Text] [PDF]

Home page
 Psychosom. Med.Home page
G. S. Sayuk, J. E. Elwing, P. J. Lustman, and R. E. Clouse
Predictors of Premature Antidepressant Discontinuation in Functional Gastrointestinal Disorders
Psychosom Med, February 1, 2007; 69(2): 173 - 181.
[Abstract] [Full Text] [PDF]

Home page
 Arch Gen PsychiatryHome page
A. J. Barsky, E. J. Orav, and D. W. Bates
Somatization Increases Medical Utilization and Costs Independent of Psychiatric and Medical Comorbidity
Arch Gen Psychiatry, August 1, 2005; 62(8): 903 - 910.
[Abstract] [Full Text] [PDF]

Home page
 Psychosom. Med.Home page
C. G. Kooiman, J. H. Bolk, R. Brand, R. W. Trijsburg, and H. G. M. Rooijmans
Is Alexithymia a Risk Factor for Unexplained Physical Symptoms in General Medical Outpatients?
Psychosom Med, December 1, 2000; 62(6): 768 - 778.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
A. R. Green, J. R. Betancourt, J. E. Carrillo, C. Pornnoppadol, G. E. Simon, and M. VonKorff
The Relation between Somatic Symptoms and Depression
N. Engl. J. Med., March 2, 2000; 342(9): 658 - 659.
[Full Text]

Home page
 Arch Fam MedHome page
B. Blackwell and N. P. De Morgan
The Primary Care of Patients Who Have Bodily Concerns
Arch Fam Med, September 1, 1996; 5(9): 457 - 463.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by the American Psychosomatic Society